Literature DB >> 4412113

Aterial blood pressure in dogs: effects of m-tyrosine alone or in combination with inhibitors of aromatic amino acid decarboxylase; relative hypotensive potencies of L-dopa, DL-m-tyrosine, and L-m-tyrosine.

D H Minsker, A L Stokes.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4412113     DOI: 10.1007/BF01939004

Source DB:  PubMed          Journal:  Experientia        ISSN: 0014-4754


× No keyword cloud information.
  13 in total

1.  Increase of cerebral catecholamines caused by 3,4-dihydroxyphenylalanine after inhibition of peripheral decarboxylase.

Authors:  G Bartholini; W P Burkard; A Pletscher
Journal:  Nature       Date:  1967-08-19       Impact factor: 49.962

2.  Modification of the cardiovascular effects of L-dopa in anesthetized dogs by inhibitors of enzymes involved in catecholamine metabolism.

Authors:  R D Robson
Journal:  Circ Res       Date:  1971-06       Impact factor: 17.367

3.  Analysis of the action of m-tyrosine on blood pressure in the conscious rat: evidence for a central hypotensive effect.

Authors:  A Rubenson
Journal:  J Pharm Pharmacol       Date:  1971-06       Impact factor: 3.765

4.  Central dopamine and noradrenaline receptor activity of the amines formed from m-tyrosine, alpha-methyl-m-tyrosine and alpha-methyldopa.

Authors:  N E Andén; S G Butcher; J Engel
Journal:  J Pharm Pharmacol       Date:  1970-07       Impact factor: 3.765

5.  Central hypotensive effect of L-3,4-dihydroxyphenylalanine in the rat.

Authors:  M Henning; A Rubenson
Journal:  J Pharm Pharmacol       Date:  1970-08       Impact factor: 3.765

6.  Evidence for a centrally mediated hypotensive effect of L-dopa in the rat.

Authors:  M Henning; A Rubenson
Journal:  J Pharm Pharmacol       Date:  1970-03       Impact factor: 3.765

7.  -Sympathetic receptor stimulation in the brain and hypotensive activity of -methyldopa.

Authors:  A Heise; G Kroneberg
Journal:  Eur J Pharmacol       Date:  1972-02       Impact factor: 4.432

8.  [The capillary barrier for dopa in brain and different organs].

Authors:  J Constantinidis; J C De La Torre; R Tissot; F Geissbuhler
Journal:  Psychopharmacologia       Date:  1969

9.  The localization of monoaminergic blood-brain barrier mechanisms.

Authors:  A Bertler; B Falck; C Owman; E Rosengrenn
Journal:  Pharmacol Rev       Date:  1966-03       Impact factor: 25.468

10.  [Pressor and depressor action of BAY 1470 (2-(2,6-Xylidino)-5,6-dihydro-4H-1,3-thiazinehydrochloride) as a consequence of its -receptor-stimulating properties].

Authors:  A Heise; G Kroneberg; K Schlossmann
Journal:  Naunyn Schmiedebergs Arch Pharmakol       Date:  1971
View more
  1 in total

1.  d-Tyrosine prevents hypertension in DOCA-saline treated uninephrectomised rats.

Authors:  B Shalita; S Dikstein
Journal:  Pflugers Arch       Date:  1979-04-30       Impact factor: 3.657

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.